Flavia-Bianca Cristian, Christian Tidona, Thomas Rückle
{"title":"Innovation at the Interface between Academia and Industry: The BioMed X Model.","authors":"Flavia-Bianca Cristian, Christian Tidona, Thomas Rückle","doi":"10.1007/164_2024_729","DOIUrl":null,"url":null,"abstract":"<p><p>In the evolving landscape of biomedical research, the convergence of molecular biology and translational medicine has ushered in a new era of pharmaceutical innovation. This paradigm shift, characterized by significant advances in targeted therapies and gene editing, emphasizes the critical role of integrating academic research - and academic researchers - within industry settings. Contemporary innovation models are moving beyond traditional, corporation-centered frameworks, adopting more open, collaborative approaches. Here, we discuss the challenges and solutions brought about by this new direction in pharma innovation and describe the BioMed X innovation model, a unique open innovation approach that has been growing continuously over the past ten years.</p>","PeriodicalId":12859,"journal":{"name":"Handbook of experimental pharmacology","volume":" ","pages":"113-136"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Handbook of experimental pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/164_2024_729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
In the evolving landscape of biomedical research, the convergence of molecular biology and translational medicine has ushered in a new era of pharmaceutical innovation. This paradigm shift, characterized by significant advances in targeted therapies and gene editing, emphasizes the critical role of integrating academic research - and academic researchers - within industry settings. Contemporary innovation models are moving beyond traditional, corporation-centered frameworks, adopting more open, collaborative approaches. Here, we discuss the challenges and solutions brought about by this new direction in pharma innovation and describe the BioMed X innovation model, a unique open innovation approach that has been growing continuously over the past ten years.
在不断发展的生物医学研究领域，分子生物学和转化医学的融合开创了医药创新的新时代。这种以靶向疗法和基因编辑取得重大进展为特征的范式转变，强调了将学术研究和学术研究人员整合到产业环境中的关键作用。当代创新模式正在超越传统的、以企业为中心的框架，采用更加开放和协作的方法。在此，我们将讨论制药创新的这一新方向所带来的挑战和解决方案，并介绍 BioMed X 创新模式，这是一种独特的开放式创新方法，在过去十年中不断发展壮大。
期刊介绍：
The Handbook of Experimental Pharmacology is one of the most authoritative and influential book series in pharmacology. It provides critical and comprehensive discussions of the most significant areas of pharmacological research, written by leading international authorities. Each volume in the series represents the most informative and contemporary account of its subject available, making it an unrivalled reference source.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
